This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lukas, C. Articles by Bartek, J. Search for Related Content PubMed PubMed Citation Articles by Lukas, C. Articles by Bartek, J.

DNA Damage-activated Kinase Chk2 Is Independent of Proliferation or Differentiation Yet Correlates with Tissue Biology¹

Institute of Cancer Biology, Danish Cancer Society [C. L., J. Bartk., L. L., J. F., N. M., T. S., J. L., J. Barte.], and Department of Pathology, University Hospital [J. F., M. S.], DK-2100 Copenhagen, Denmark

The Chk2 kinase is a tumor suppressor and key transducer of DNA-damage checkpoints. We show that the human Chk2 protein is relatively stable, nuclear, and responding to -radiation throughout the cell cycle. Contrary to the retinoblastoma protein-regulated, labile Chk1 kinase restricted to S-G₂ phases, Chk2 remains activatable even in quiescent and differentiating cells. In human tissues, Chk2 is homogeneously expressed in renewing cell populations such as epidermis or intestine, heterogeneous in conditionally renewing tissues, and absent or cytoplasmic in static tissues such as muscle or brain. These data highlight striking differences between Chk2 and Chk1 and show unexpected correlation of Chk2 expression with tissue biology.

This article has been cited by other articles:

				H. Jiang, H. C. Reinhardt, J. Bartkova, J. Tommiska, C. Blomqvist, H. Nevanlinna, J. Bartek, M. B. Yaffe, and M. T. Hemann The combined status of ATM and p53 link tumor development with therapeutic response Genes & Dev., August 15, 2009; 23(16): 1895 - 1909. [Abstract] [Full Text] [PDF]

				C. M. Lovly, L. Yan, C. E. Ryan, S. Takada, and H. Piwnica-Worms Regulation of Chk2 Ubiquitination and Signaling through Autophosphorylation of Serine 379 Mol. Cell. Biol., October 1, 2008; 28(19): 5874 - 5885. [Abstract] [Full Text] [PDF]

				P. G. Nuciforo, C. Luise, M. Capra, G. Pelosi, and F. d'Adda di Fagagna Complex engagement of DNA damage response pathways in human cancer and in lung tumor progression Carcinogenesis, October 1, 2007; 28(10): 2082 - 2088. [Abstract] [Full Text] [PDF]

				A. N. Tse, R. Carvajal, and G. K. Schwartz Targeting Checkpoint Kinase 1 in Cancer Therapeutics Clin. Cancer Res., April 1, 2007; 13(7): 1955 - 1960. [Abstract] [Full Text] [PDF]

				M. Mahmoudi, J. Mercer, and M. Bennett DNA damage and repair in atherosclerosis Cardiovasc Res, July 15, 2006; 71(2): 259 - 268. [Abstract] [Full Text] [PDF]

				Y. Pommier, J. N. Weinstein, M. I. Aladjem, and K. W. Kohn Chk2 molecular interaction map and rationale for chk2 inhibitors. Clin. Cancer Res., May 1, 2006; 12(9): 2657 - 2661. [Abstract] [Full Text] [PDF]

				C.-M. Aliouat-Denis, N. Dendouga, I. Van den Wyngaert, H. Goehlmann, U. Steller, I. van de Weyer, N. Van Slycken, L. Andries, S. Kass, W. Luyten, et al. p53-Independent Regulation of p21Waf1/Cip1 Expression and Senescence by Chk2 Mol. Cancer Res., November 1, 2005; 3(11): 627 - 634. [Abstract] [Full Text] [PDF]

				S. L. Maude and G. H. Enders Cdk Inhibition in Human Cells Compromises Chk1 Function and Activates a DNA Damage Response Cancer Res., February 1, 2005; 65(3): 780 - 786. [Abstract] [Full Text] [PDF]

				L. Latella, J. Lukas, C. Simone, P. L. Puri, and J. Bartek Differentiation-Induced Radioresistance in Muscle Cells Mol. Cell. Biol., July 15, 2004; 24(14): 6350 - 6361. [Abstract] [Full Text] [PDF]

				T. O'Neill, L. Giarratani, P. Chen, L. Iyer, C.-H. Lee, M. Bobiak, F. Kanai, B.-B. Zhou, J. H. Chung, and G. A. Rathbun Determination of Substrate Motifs for Human Chk1 and hCds1/Chk2 by the Oriented Peptide Library Approach J. Biol. Chem., May 3, 2002; 277(18): 16102 - 16115. [Abstract] [Full Text] [PDF]